Startup Xagenic Receives $1.1M to Commercialize Chip-based MDx Technology
July 26, 2011
Startup Xagenic Receives $1.1M to Commercialize Chip-based MDx Technology
Xagenic's technology uses nanostructured microelectrodes to create highly sensitive nucleic acid sensors that it claims can detect DNA and RNA "at record-breaking speed."
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- CGI Pledges to Launch Two More Array Tests This Year after 'Busy' Q1
May 28, 2013 / BioArray News - Kindstar to Offer Illumina's Infinium Dx CytoSNP-12 BeadChip in China
April 23, 2013 / BioArray News - New Infectious Disease MDx Firm Mobidiag Formed from Merger
April 12, 2013 / GenomeWeb Daily News - CombiMatrix to Raise $2M in Direct Offering
March 20, 2013 / GenomeWeb Daily News - Cancer Genetics Lowers Expected Proceeds from IPO, Increases 2012 Revenues
March 4, 2013 / GenomeWeb Daily News